Format

Send to

Choose Destination
Vaccine. 2010 Oct 8;28(43):7123-9. doi: 10.1016/j.vaccine.2010.07.028. Epub 2010 Jul 24.

Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.

Author information

1
Division of Bacterial Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS C-25, Atlanta, GA 30333, USA. RHajjeh@cdc.gov, rfh5@cdc.gov

Abstract

The introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries has suffered from a long delay. Between 2005 and 2009, a surge in Hib vaccine adoption took place, particularly among GAVI-eligible countries. Several factors contributed to the increase in Hib vaccine adoption, including support provided by the Hib Initiative, a project funded by the GAVI Alliance in 2005 to accelerate evidence-informed decisions for use of Hib vaccine. This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines.

PMID:
20659515
DOI:
10.1016/j.vaccine.2010.07.028
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center